Introduction Percutaneous coronary intervention (PCI) is the dominant strategy used for coronary revascularization in acute myocardial infarction (MI). In the United States, approximately 600,000 patients are discharged from the hospital with a principal diagnosis of acute MI (see Chapter 2…
Hypertension remains an almost ubiquitous entity as a chronic disease around the world today. Its relevance lies in the fact that it is one of the most common risk factors responsible for cardiovascular morbidity and mortality. It is estimated that…
Platelets play a central role in the pathobiology of atherogenesis and atherothrombosis. Therefore therapies that are directed toward platelet inhibition are widely used in patients with established coronary heart disease (CHD) or in moderate- to high-risk individuals for primary prevention…
Dr. Deepak L. Bhatt discloses the following relationships: Advisory Board : Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, Regado Biosciences; Board of Directors : Boston VA Research Institute, Society of Cardiovascular Patient Care; Chair : American Heart Association Get With…
Additional content is available online at Elsevier eBooks for Practicing Clinicians Peripheral vascular disease is a general term that includes pathologic processes affecting arteries, veins, and lymphatics (see Chapter 43 ). This chapter focuses on catheter-based endovascular treatment of large-…
Acknowledgments The authors acknowledge the late Donald Baim, MD, Fred Resnic, MD, Jeff Popma, MD, and Laura Mauri, MD, for their previous contributions to this chapter, and Thomas Lee, MD, for his previous contribution to the Guidelines section. Additional content…